Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The CagriSema program, combining cagrilintide with semaglutide, has demonstrated: 15.1% mean body weight reduction at 32 weeks in REDEFINE 1 trial Approximately 15-17% weight loss in various phase 3 timepoints Superior outcomes compared to semaglutide monotherapy Manageable safety profile with expected GI side effects Cagrilintide 10mg remains an important research tool for scientists exploring amylin analogue applications
PLoS One 16(6):0252899 Ma L, Kong L, Gui R, Yang X, Zhang J, Gong Q, Qin D, Zhuang M, Ashraf U, Mo Z (2021) Application of hydrogen-rich water modulates physio-biochemical functions and early growth of fragrant rice under Cd and Pb stress
Disclaimer PepXpress will not provide information relating to the use of our research chemicals
Raun K et al., Eur J Endocrinol, 1998 139(5):552-561
US$ 22.62
US$ 24.50
US$ 24.13
US$ 24.98
US$ 28.97
